Cetuximab and biomarkers in non-small-cell lung carcinoma

Código QR

Cetuximab and biomarkers in non-small-cell lung carcinoma

Nitin Patil, Mohammed Abba, Heike AllgayerDepartment of Experimental Surgery, Medical Faculty Mannheim, University of Heidelberg and Molecular Oncology of Solid Tumors Unit, German Cancer Research Center (DKFZ), Heidelberg, GermanyAbstract: Cancer progression is a highly complex process that is driv...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Patil N, Abba M, Allgayer H
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2012
Materias:	Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/1a1a43be84624441be7288e23a2b1851
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

EGFR targeted therapy in non-small cell lung cancer: potential role of cetuximab
por: Chad A Reade, et al.
Publicado: (2009)

Clinical and comparative utility of afatinib in non-small cell lung cancer
por: D'Arcangelo M, et al.
Publicado: (2014)

Clinical use of crizotinib for the treatment of non-small cell lung cancer
por: Roberts PJ
Publicado: (2013)

The emerging role of nimotuzumab in the treatment of non-small cell lung cancer
por: William Boland, et al.
Publicado: (2010)

Cetuximab-conjugated iron oxide nanoparticles for cancer imaging and therapy
por: Tseng SH, et al.
Publicado: (2015)

Cetuximab: its unique place in head and neck cancer treatment
por: Specenier P, et al.
Publicado: (2013)

The contribution of cetuximab in the treatment of recurrent and/or metastatic head and neck cancer
por: Mohamedtaki A Tejani, et al.
Publicado: (2010)

Focus on the potential role of ficlatuzumab in the treatment of non-small cell lung cancer
por: D&#39;Arcangelo M, et al.
Publicado: (2013)

Management of patients with advanced non-small cell lung cancer: role of gefitinib
por: Vamsidhar Velcheti, et al.
Publicado: (2010)

First line treatment of advanced non-small-cell lung cancer – specific focus on albumin bound paclitaxel
por: Gupta N, et al.
Publicado: (2013)

Advancements in next-generation sequencing for diagnosis and treatment of non-small-cell lung cancer
por: Ying-Qiang Lu, et al.
Publicado: (2017)

Current status of vandetanib (ZD6474) in the treatment of non-small cell lung cancer
por: Jaclyn Flanigan, et al.
Publicado: (2010)

Combination of TRAIL and actinomycin D liposomes enhances antitumor effect in non-small cell lung cancer
por: Guo LG, et al.
Publicado: (2012)

Clinical Outcomes of Cetuximab and Paclitaxel after Progression on Immune Checkpoint Inhibitors in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
por: Shinsuke Suzuki, et al.
Publicado: (2021)

Detection of micrometastases in peripheral blood of non-small cell lung cancer with a refined immunomagnetic nanoparticle enrichment assay
por: Li Q, et al.
Publicado: (2011)

Functional promoter rs189037 variant of ATM is associated with decrease in lung diffusing capacity after irradiation for non–small-cell lung cancer
por: Jose Luis Lopez Guerra, et al.
Publicado: (2018)

GEM-loaded magnetic albumin nanospheres modified with cetuximab for simultaneous targeting, magnetic resonance imaging, and double-targeted thermochemotherapy of pancreatic cancer cells
por: Wang L, et al.
Publicado: (2015)

Clinical utility of ramucirumab in non-small-cell lung cancer
por: Uprety D
Publicado: (2019)

Delivery of curcumin by directed self-assembled micelles enhances therapeutic treatment of non-small-cell lung cancer [Corrigendum]
por: Zhu WT, et al.
Publicado: (2017)

GE11-modified liposomes for non-small cell lung cancer targeting: preparation, ex vitro and in vivo evaluation
por: Cheng L, et al.
Publicado: (2014)

Phenotypic Changes of LncRNA Hotair in Non-Small-Cell Lung Cancer and Its Clinical Application
por: Haihua Huang, et al.
Publicado: (2021)

Clinical Outcomes of Chemotherapeutic Molecules as Single and Multiple Agents in Advanced Non-Small-Cell Lung Carcinoma (NSCLC) Patients
por: Ting Yoon Kwan, et al.
Publicado: (2021)

First-line treatment of EGFR-mutant non-small-cell lung cancer: the role of erlotinib and other tyrosine kinase inhibitors
por: Nguyen KS, et al.
Publicado: (2012)

Soluble CD40 in plasma and malignant pleural effusion with non-small cell lung cancer: A potential marker of prognosis
por: Chuan-Yong Mu, et al.
Publicado: (2015)

Decreased lung carcinoma cell density on select polymer nanometer surface features for lung replacement therapies
por: Lijuan Zhang, et al.
Publicado: (2010)

In vivo evaluation of cetuximab-conjugated poly(γ-glutamic acid)-docetaxel nanomedicines in EGFR-overexpressing gastric cancer xenografts [Corrigendum]
por: Sreeranganathan M, et al.
Publicado: (2019)

2'-(2-bromohexadecanoyl)-paclitaxel conjugate nanoparticles for the treatment of non-small cell lung cancer in an orthotopic xenograft mouse model
por: Peng L, et al.
Publicado: (2014)

Advances in Biomarkers for Immunotherapy of Non-small Cell Lung Cancer
por: Chuan HUANG, et al.
Publicado: (2021)

Serum midkine as non-invasive biomarker for detection and prognosis of non-small cell lung cancer
por: Louisa Stern, et al.
Publicado: (2021)

Application of multifunctional targeting epirubicin liposomes in the treatment of non-small-cell lung cancer
por: Song X, et al.
Publicado: (2017)

Clinical Characteristics and Prognosis of HER2 Gene Phenotype in Patients with Non-Small Cell Lung Cancer
por: Diao WY, et al.
Publicado: (2021)

Functionalized selenium nanoparticles for targeted delivery of doxorubicin to improve non-small-cell lung cancer therapy
por: Xia Y, et al.
Publicado: (2018)

New targeted treatments for non-small-cell lung cancer – role of nivolumab
por: Zago G, et al.
Publicado: (2016)

Editorial: New Advances in Non-small Cell Lung Cancer Management: Immune Modulation and Targeted Therapies
por: Thierry Berghmans, et al.
Publicado: (2021)

Use tumor suppressor genes as biomarkers for diagnosis of non-small cell lung cancer
por: Chuantao Zhang, et al.
Publicado: (2021)

Pluronic P105/F127 mixed micelles for the delivery of docetaxel against Taxol-resistant non-small cell lung cancer: optimization and in vitro, in vivo evaluation
por: Fang X, et al.
Publicado: (2013)

Quantum dots immunofluorescence histochemical detection of EGFR gene mutations in the non-small cell lung cancers using mutation-specific antibodies
por: Qu YG, et al.
Publicado: (2014)

Spotlight on necitumumab in the treatment of non-small-cell lung carcinoma
por: Thakur MK, et al.
Publicado: (2017)

Application of Multifunctional Targeting Epirubicin Liposomes in the Treatment of Non-Small-Cell Lung Cancer [Corrigendum]
por: Song X, et al.
Publicado: (2021)

Ultra-small gadolinium oxide nanocrystal sensitization of non-small-cell lung cancer cells toward X-ray irradiation by promoting cytostatic autophagy
por: Li FF, et al.
Publicado: (2019)